Clinically Evident Portal Hypertension (CEPH) is Associated with Low IGF-1 in Children with Chronic Liver Disease

被引：0
|
作者：
Whitehead, B. [1 ]
Mohammad, S. [1 ]
Kelly, S. [1 ]
Josefson, J. [2 ]
Mithal, L. [3 ]
Alonso, E. M. [1 ]
机构：
[1] Ann & Robert H Lurie Childrens Hosp Chicago, Div Gastroenterol Hepatol & Nutr, Chicago, IL 60611 USA
[2] Ann & Robert H Lurie Childrens Hosp Chicago, Div Endocrinol, Chicago, IL 60611 USA
[3] Ann & Robert H Lurie Childrens Hosp Chicago, Div Infect Dis, Chicago, IL 60611 USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2021年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
1178
引用
收藏
页码：794 / 795
页数：2
相关论文
共 50 条
  • [1] CLINICALLY EVIDENT PORTAL HYPERTENSION ASSOCIATED WITH LOW IGF-1 IN CHILDREN WITH CHRONIC LIVER DISEASE
    Whitehead, Bridget
    Mohammad, Saeed
    Kelly, Susan
    Josefson, Jami
    Mithal, Leena B.
    Alonso, Estella M.
    HEPATOLOGY, 2020, 72 : 1087 - 1087
  • [2] Chronic liver disease and portal hypertension in children
    Anon
    Ultrasound in Medicine and Biology, 2000, 26 (SUPPL. 2):
  • [3] Role of noninvasive tools for prediction of clinically evident portal hypertension in children
    Kumar, Aditi
    Lal, Sadhna B.
    Bhatia, Anmol
    Das, Ashim
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2020, 32 (08) : 931 - 937
  • [4] Clinically significant portal hypertension in chronic liver disease: Always cirrhosis?
    Rodrigues, S.
    Berzigotti, A.
    Montani, M.
    De Gottardi, A.
    Bosch, J.
    JOURNAL OF HEPATOLOGY, 2018, 68 : S734 - S734
  • [5] Letter: The Prognostic Role of IGF-1 in Chronic Liver Disease
    Osama, Muhammad
    Ubaid, Safiyyah
    Ubaid, Maryam
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2025, 61 (01) : 226 - 227
  • [6] Noninvasive Detection of Clinically Significant Portal Hypertension in Compensated Advanced Chronic Liver Disease
    Vuille-Lessard, Elise
    Rodrigues, Susana G.
    Berzigotti, Annalisa
    CLINICS IN LIVER DISEASE, 2021, 25 (02) : 253 - 289
  • [7] Impact of clinically evident portal hypertension on the course of hepatocellular carcinoma in patients listed for liver transplantation
    Faitot, Francois
    Allard, Marc-Antoine
    Pittau, Gabriella
    Ciacio, Oriana
    Adam, Rene
    Castaing, Denis
    Cunha, Antonio Sa
    Pelletier, Gilles
    Cherqui, Daniel
    Samuel, Didier
    Vibert, Eric
    HEPATOLOGY, 2015, 62 (01) : 179 - 187
  • [8] FIBROSCAN® IS A GOOD PREDICTOR OF HVPG, CLINICALLY SIGNIFICANT PORTAL HYPERTENSION AND COMPLICATIONS IN CHRONIC LIVER DISEASE
    Kitson, M. T.
    Roberts, S. K.
    Colman, J. C.
    Bailey, M.
    Kemp, W. W.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S250 - S251
  • [9] HepQuant SHUNT Detects Portal Hypertension in Early Stages of Clinically Compensated Chronic Liver Disease
    Wieland, Amanda
    Etzion, Ohad
    Ali, Rabab O.
    Levy, Elliot
    Kleiner, David E.
    Helmke, Steve M.
    Heller, Theo
    Everson, Gregory T.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2022, 20 (04) : e890 - e894
  • [10] Clinically Evident Portal Hypertension Is an Independent Risk Factor of Hepatocellular Carcinoma Recurrence Following Liver Transplantation
    Kornberg, Arno
    Seyfried, Nick
    Friess, Helmut
    JOURNAL OF CLINICAL MEDICINE, 2025, 14 (06)
12345